Steven Cohen’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Steven Cohen's IRD Position: Q3 2026 in Review
Steven Cohen sold out of Opus Genetics (IRD) in Q3 2026, closing a stake of 18,922 shares — an estimated $77.8K sold.
Steven Cohen first reported a position in IRD in Q2 2026 and held it in 1 quarter. The position peaked at $77.8K in Q2 2026. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Steven Cohen reported no remaining Opus Genetics position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 18,922 Opus Genetics shares in Q3 2026, an estimated $77.8K.
- Steven Cohen first reported a position in Opus Genetics in Q2 2026 and held it in 1 quarter.
- Steven Cohen's Opus Genetics position peaked at $77.8K in Q2 2026.
- 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.